8-K: Mirion Technologies Reports Strong Q4 and Full Year 2023 Results, Issues Positive 2024 Guidance

Mirion Technologies announced a 5.7% increase in fourth-quarter revenue and provided a positive outlook for 2024, including revenue growth of 5% to 7%.

Summary

• Mirion Technologies reported a 5.7% increase in revenue for the fourth quarter of 2023, reaching $230.4 million, compared to $217.9 million in the same period last year.
• The company's net loss significantly improved to $15.2 million in Q4 2023, a 90.1% improvement from a net loss of $153.4 million in Q4 2022.
• Adjusted EBITDA for the fourth quarter was $61.0 million, an 8.2% increase from $56.4 million in the same period last year.
• Net loss per share for the fourth quarter was $0.08, compared to $0.85 in the fourth quarter of 2022.
• Adjusted earnings per share for the quarter was $0.15, compared to $0.11 in the same period last year.
• For the full year 2023, Mirion achieved record revenue and adjusted EBITDA, with substantial improvements in cash generation and leverage.
• Mirion has issued full-year 2024 guidance, projecting revenue growth of 5% to 7%, adjusted EBITDA between $193 million and $203 million, adjusted EPS of $0.37 to $0.42, and adjusted free cash flow of $65 million to $85 million.

Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to strong Q4 results, improved profitability, and optimistic 2024 guidance. The company's focus on growth and operational improvements is also encouraging.

Positives

• The company experienced strong organic growth in both business segments during the fourth quarter.
• Customer engagement across all end markets remains robust.
• Mirion enters 2024 with a record backlog position, providing solid top-line coverage.
• The company expects to expand margins and free cash flow in 2024.
• Vertical market conditions are positive, supporting continued growth.
• The company has improved cash generation and leverage.

Negatives

• The company reported a net loss of $15.2 million for the fourth quarter, although this is a significant improvement year-over-year.
• The company is still reporting a net loss per share of $0.08 for the fourth quarter.

Risks

• The company's guidance contains forward-looking statements, and actual results may differ materially due to various uncertainties and risks.
• These risks include changes in domestic and foreign business, market, economic, financial, political, and legal conditions.
• Other risks include government budget changes, public perception of nuclear radiation, and the company's ability to manage its supply chain and competition.
• The company also faces risks related to information technology system failures, cybersecurity threats, and the implementation of new information systems.
• There are risks related to the global scope of operations, including fluctuations in foreign currency exchange rates, interest rates, and inflation.

Future Outlook

Mirion anticipates sustained momentum in the business, with positive vertical market conditions and plans to expand margins and free cash flow in 2024. The company is confident in its strategic positioning and ability to deliver on its financial expectations.

Management Comments

• 2023 was an excellent year for Mirion. We delivered record revenue and adjusted EBITDA, and substantially improved cash generation and leverage, stated Thomas Logan, Mirions Chief Executive Officer.
• Looking at our fourth quarter results, both business segments generated organic growth against tough comparisons from the same period last year.
• Customer engagement across our end markets remains strong and we enter 2024 with solid top-line coverage accruing from a record backlog position.
• Today, we are initiating financial guidance for 2024 that reflects sustained momentum in the business, continued Mr. Logan.
• Vertical market conditions are positive, and we are well-positioned to deliver solid organic growth.
• We expect to expand margins and free cash flow this year, as we drive continued operational improvement across the enterprise.
• I am confident in our strategic positioning and believe we have the right plans in place to deliver the financial expectations we have published today.

Industry Context

Mirion's results reflect a positive trend in the radiation detection and measurement industry, with strong demand across medical, nuclear, defense, and research sectors. The company's focus on organic growth and operational improvements aligns with industry best practices for sustainable growth and profitability.

Comparison to Industry Standards

• Mirion's 5.7% revenue growth in Q4 is solid, but it is important to compare this to peers such as Thermo Fisher Scientific (TMO) and PerkinElmer (PKI), which also operate in related scientific and medical equipment markets.
• Thermo Fisher Scientific, for example, has reported organic revenue growth in the low single digits in recent quarters, suggesting Mirion's growth is competitive.
• Mirion's adjusted EBITDA margin of 26.5% in Q4 is a key metric to compare against industry benchmarks. Companies like Varex Imaging (VREX) in the medical imaging space often have similar margins, but it is important to look at the specific segments.
• The projected 5-7% revenue growth for 2024 is a positive sign, but it will be crucial to see how this compares to the growth rates of other companies in the radiation detection and measurement space, such as Canberra Industries or Ludlum Measurements.
• Mirion's focus on improving free cash flow is also a positive sign, as this is a key metric for investors. Comparing Mirion's free cash flow generation to companies like Agilent Technologies (A) in the analytical instruments space will provide a better understanding of its performance.

Stakeholder Impact

• Shareholders will likely react positively to the improved financial results and positive 2024 guidance.
• Employees may benefit from the company's growth and improved financial performance.
• Customers can expect continued innovation and high-quality products and services.
• Suppliers may see increased business opportunities due to the company's growth.
• Creditors may view the company as a lower credit risk due to its improved financial position.

Next Steps

• Mirion will host a conference call on February 14, 2024, to discuss the financial results.
• The company will continue to execute its strategic plans to achieve its 2024 financial targets.
• Mirion will provide updates on its progress through its investor relations website, SEC filings, and other public channels.

Key Dates

Keywords

radiation detection, financial results, EBITDA, revenue growth, adjusted EPS, free cash flow, guidance, medical, nuclear, defense, research